机构:[1]MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU, 34295 MontpellierCedex 5, France[2]INSERM U 1168, VIMA: Ageing and Chronic DiseasesEpidemiological and Public Health Approaches, Villejuif Université VersaillesSt-Quentin-en-Yvelines, UMR-S 1168, Montigny Le Bretonneux, France[3]European Forum for Research and Education in Allergy and Airway Diseases(EUFOREA), Brussels, Belgium[4]Charité-Universitätsmedizin Berlin, CorporateMember of Freie Universität Berlin, Humboldt-Uniersität zu Berlin, Berlin,Germany[5]Department of Dermatology and Allergy Member of GA2LEN,Comprehensive Allergy‑Centre, Berlin Institute of Health, Berlin, Germany[6]Department of Clinical Epidemiology and Biostatistics, McMaster University,Hamilton, ON, Canada[7]Division of Allergy, Immunology, and Transplantation(DAIT), National Institute of Allergy and Infectious Diseases, NIH, Bethesda,USA[8]National Institute for Health and Welfare, Helsinki, Finland[9]Deptof Otorhinolaryngology, Univ Hospitals Leuven, Louvain, Belgium[10]AcademicMedical Center, Univ of Amsterdam, Amsterdam, The Netherlands[11]Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital and Beijing Institute of Otolaryngology, Beijing, China.临床科室耳鼻咽喉-头颈外科研究所耳鼻咽喉科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[12]State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
Background In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Sante as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
基金:
POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health); ARIA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM121334] Funding Source: NIH RePORTER
第一作者机构:[1]MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU, 34295 MontpellierCedex 5, France[2]INSERM U 1168, VIMA: Ageing and Chronic DiseasesEpidemiological and Public Health Approaches, Villejuif Université VersaillesSt-Quentin-en-Yvelines, UMR-S 1168, Montigny Le Bretonneux, France[3]European Forum for Research and Education in Allergy and Airway Diseases(EUFOREA), Brussels, Belgium[4]Charité-Universitätsmedizin Berlin, CorporateMember of Freie Universität Berlin, Humboldt-Uniersität zu Berlin, Berlin,Germany
推荐引用方式(GB/T 7714):
J. Jean Bousquet,Holger J. Schünemann,Alkis Togias,et al.Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases[J].CLINICAL AND TRANSLATIONAL ALLERGY.2019,9(1):doi:10.1186/s13601-019-0279-2.
APA:
J. Jean Bousquet,Holger J. Schünemann,Alkis Togias,Marina Erhola,Peter W. Hellings...&Nan S. Zhong.(2019).Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.CLINICAL AND TRANSLATIONAL ALLERGY,9,(1)
MLA:
J. Jean Bousquet,et al."Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases".CLINICAL AND TRANSLATIONAL ALLERGY 9..1(2019)